HJOE Stock UPDATES Hangover Joe's Holding Corp. (HJOE) 0.0140

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hangover Joe's Holding Corp. (HJOE) 0.0140 $HJOE

Git-R-Done-Energy (HJOE) Updates Marketing Plan Based on Product Launch Data
ACCESSWIRE - Wed Sep 03, 9:35AM CDT
Promising Sell Through Rates of Healthy Energy Drink Causes (HJOE) to Update Marketing Plan

Hangover Joe's Holding Corporation (HJOE) - Announces Settlement of Financial Dispute
ACCESSWIRE - Tue Aug 12, 12:37PM CDT
HJOE Settles Financial Dispute

Git-R-Done-Energy to Headline ASD Trade Show as Breakout Healthy Energy Drink - Git-R-Done-Energy featuring Larry The Cable Guy
ACCESSWIRE - Mon Aug 04, 6:32AM CDT
Healthy Energy Shots with Larry The Cable Guy New Alternitive to Caffine in C-Stores

Git-R-Done Energy Rolls Out Healthy Energy Shots to Distributors and Truck Jobbers
eTeligis - Wed Jul 23, 12:29PM CDT
DENVER, CO, United States, via eTeligis Inc., 07/23/2014 - - Hangover Joe's Holding Corporation (OTCQB:HJOE), the maker of "The Hangover" Recovery Shot and developers of an innovative state of the art proprietary Git-R-Done-Energy Shot, along with Git-R-Done Productions, Inc. and Larry the Cable Guy, announced initial shipments of Git-R-Done-Energy, healthy energy drinks to distributors, DSD, Truck Jobbers and stores. Matthew Veal, CEO ofHangover Joe's, said, "We had a very good initial production run and stores are starting to put the product onto the shelves, and initial sales are promising, so its a very exciting time for the Company." "We are moving Git-R-Done Energy shots with DSD houses such as Core Mark, but our focus is on Truck Jobbers and with distributors who are actually in the stores and putting the product on the counter," said Shawn Adamson Co-Founder and VP of Sales for Hangover Joe's. "We have new distributors coming to us weekly wanting to sell Git-R-Done Energy shots. This energy drink is quite different than any other on the market as it is caffeine free and sugar free and yet it still manages to pack a punch of long lasting healthy energy. We feel that with some of therecent negative news headlines regarding caffeine, our release of Larry the Cable Guy's Git-R-Done Energy shots which meet customers needs for an energy product without sugar or added caffeine is very timely."

March 18th Marks the Third Annual Celebration of Hangover Joe's Day
eTeligis - Mon Mar 17, 9:19AM CDT
HANGOVER JOE'S HOLDING CORPORATION(OTCQB:HJOE), the maker of "The Hangover" Recovery Shot, announces the 3rd annual celebration of Hangover Joe's Day on March 18th.Honoring those of you who tipped a pint or two while enjoying everything Irish on St. Patrick's Day, we invite you to join us in a celebratory two-ounce toast to rapid hangover recovery on Tuesday, March 18, 2014 -- Hangover Joe's Day.Currently available in a growing number of retail locations and growing, Hangover Joe's two-ounce Recovery Shot replenishes your body with key vitamins and minerals that are depleted when you drink alcohol.

Hangover Joe's (HJOE) Introduces Git-R-Done-Energy With "Larry the Cable Guy" to Provide Healthy Energy to Consumers
Marketwire - Mon Mar 10, 7:18AM CDT
Hangover Joe's Holding Corporation (OTCQB: HJOE). The maker of "The Hangover" Recovery Shot recently announced its huge new brand extension for the Company, Git-R-Done Energy (trademark registered) with Git-R-Done Productions, Inc. (Larry the Cable Guy), which is a healthy, all natural energy drink. In discussing the new product and beverage category, Matthew Veal, CEO for Hangover Joe's, stated, "We saw a need in the market for an all-natural, non-caffeinated health & wellness energy product that provides hours of long lasting energy without all of the caffeine and sugar. The energy drink market has come under fire in the last year or so for energy drinks having a high concentration of these substances. Git-R-Done Energy Drink is not your normal energy drink. We believe this is the perfect product for the market at this time."

OTC Daily Alert Stock Watch - Hangover Joe's Holding Corporation (OTCQB: HJOE)
WorldStockWire - Wed Aug 28, 4:15PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

Hangover Joe's Has at Least 200 Reasons to Celebrate 2013!
Business Wire - Fri Dec 28, 3:11PM CST
Hangover Joe's Recovery Shots, the nation's number one hangover recovery shot and the leader in the functional lifestyle beverage market, is celebrating a banner year and preparing for a pain-free New Year's Eve! In 2012, Hangover Joe's Inc. became a publicly traded company (OTCBB: HJOE) and saw a 200% growth in sales from 2011. The brand also began international distribution shipping product to Canada, Australia and New Zealand. Said CEO Michael Jaynes, "We see continued growth and success across the U.S. and around the world for the brand because consumers love our product."




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading